Capital Market Strategies’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $232K | Sell |
3,627
-100
| -3% | -$6.41K | 0.16% | 120 |
|
|
2025
Q1 | $236K | Hold |
3,727
| – | – | 0.16% | 120 |
|
|
2024
Q4 | $248K | Hold |
3,727
| – | – | 0.14% | 130 |
|
|
2024
Q3 | $260K | Sell |
3,727
-50
| -1% | -$3.49K | 0.16% | 124 |
|
|
2024
Q2 | $245K | Hold |
3,777
| – | – | 0.15% | 129 |
|
|
2024
Q1 | $244K | Hold |
3,777
| – | – | 0.19% | 119 |
|
|
2023
Q4 | $249K | Buy |
3,777
+100
| +3% | +$6.58K | 0.22% | 121 |
|
|
2023
Q3 | $205K | Hold |
3,677
| – | – | 0.2% | 130 |
|
|
2023
Q2 | $225K | Buy |
+3,677
| New | +$225K | 0.21% | 122 |
|
|
2023
Q1 | – | Sell |
-3,677
| Closed | -$233K | – | 104 |
|
|
2022
Q4 | $233K | Hold |
3,677
| – | – | 0.25% | 109 |
|
|
2022
Q3 | $217K | Hold |
3,677
| – | – | 0.24% | 113 |
|
|
2022
Q2 | $212K | Hold |
3,677
| – | – | 0.22% | 127 |
|
|
2022
Q1 | $228K | Sell |
3,677
-1,050
| -22% | -$65.1K | 0.2% | 131 |
|
|
2021
Q4 | $337K | Buy |
+4,727
| New | +$337K | 0.28% | 91 |
|